The Central military Commission of China approved the use of the military experimental vaccines against coronavirus, reported by BangkokPost on June 29.
According to the website, the drug developed by pharmaceutical company CanSino Biologic in cooperation with the Beijing Institute of biotechnology, Academy of military medical Sciences of China. The vaccine has successfully passed first and second phases of clinical trials.
The test results showed that the vaccine has a good safety profile and is able to prevent disease caused by a coronavirus, was reported.
The Chinese military has agreed on the use of the drug from June 25 for one year.
Flash coronavirus infection COVID-19 began in late 2019 in China. March 11, 2020, the world health organization declared the spread of the coronavirus pandemic.
According to data from the American Johns Hopkins University, in China infected 84 757 people died 4641 man recovered – 79 610.
The total number of infected people in the world reached almost 10.2 million, of which nearly cured of 5.17 million and 503 thousand died.